This trial is withdrawn!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Hypotension, Shock, Septic or Sepsis
and you are
over 18
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The purpose of this study is to determine whether midodrine administration decreases duration of intravenous vasopressors and intensive care unit length of stay for patients in septic shock.

Provided treatments

  • Drug: Midodrine
  • Drug: placebo
Tris trial is registered with FDA with number: NCT02771158. The sponsor of the trial is Northwell Health and it is looking for 0 volunteers for the current phase.
Official trial title:
A Randomized Controlled Trial of Midodrine During Recovery Phase From Septic Shock